Analyst Ranking
Bottom 4%
#4686 out of 4870 analysts
Average Return
-4.92%
Win Rate
42%63 out of 151
Risk vs Reward
Poor
Good

Edward Woo's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Quantum Computing IncQUBT
+593.18%$0.88$6.10
2023-11-23 -
2024-11-22
Buy
Duos Technologies Group IncDUOT
+178.75%$2.40$6.69
2024-09-10 -
2025-05-01
Buy
Quantum Computing IncQUBT
+163.91%$2.66$7.02
2024-11-12 -
2025-05-01
Buy
Duos Technologies Group IncDUOT
+160.31%$2.57$6.69
2024-06-06 -
2025-05-01
Buy
Gamestop CorpGME
+156.19%$4.64$11.90
2012-08-16 -
2013-08-16
Buy

Edward Woo Analyst Color

Get additional color on Edward Woo's coverage of popular stocks

Edward Woo's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nrx Pharmaceuticals IncNRXP
5Buy$46.00+2,111.54%Maintains
3 days ago
Duos Technologies Group IncDUOT
5Buy$9.00+34.53%Maintains
4 days ago
Quantum Computing IncQUBT
3Buy$14.00+99.43%Maintains
4 days ago
Knightscope IncKSCP
2Buy$30.00+484.80%Maintains
4 days ago
Banzai International IncBNZI
4Buy$26.00+2,376.19%Maintains
4 days ago
Renovorx IncRNXT
4Buy$11.00+1,011.11%Maintains
4 days ago
Surgepays IncSURG
6Buy$8.75+209.19%Maintains
10 days ago
Biosig Technologies IncBSGM
3Buy$2.50+104.92%Maintains
11 days ago
Verb Technology Company IncVERB
3Buy$60.00+1,011.11%Maintains
11 days ago
Envoy Medical IncCOCH
4Buy$9.25+570.29%Maintains
11 days ago
Society Pass IncorporatedSOPA
4Buy$14.00+1,086.44%Maintains
11 days ago
Sintx Technologies IncSINT
1Buy$30.00+1,015.24%Maintains
11 days ago
Endra Life Sciences IncNDRA
2Buy$50.00+594.44%Maintains
11 days ago
Cingulate IncCING
1Buy$60.00+1,295.35%Maintains
11 days ago
Plus Therapeutics IncPSTV
3Buy$20.00+2,976.92%Maintains
11 days ago
Pavmed IncPAVM
5Buy$19.50+2,278.05%Maintains
11 days ago
Lucid Diagnostics IncLUCD
5Buy$7.50+481.40%Maintains
11 days ago
Atossa Therapeutics IncATOS
4Buy$7.25+760.02%Maintains
11 days ago
Phunware IncPHUN
5Buy$12.00+304.04%Maintains
11 days ago
Myomo IncMYO
3Buy$11.00+132.07%Maintains
2 months ago
Alzamend Neuro IncALZN
4Buy$20.00+2,907.52%Maintains
2 months ago
Groupon IncGRPN
8Buy$19.00+3.43%Maintains
2 months ago
Daxor CorpDXR
3Buy$25.00+221.34%Maintains
2 months ago
Aemetis IncAMTX
2Buy$19.00+1,361.54%Maintains
2 months ago
Electronic Arts IncEA
2Buy$160.00+10.27%Maintains
2 months ago
Take Two Interactive Software IncTTWO
11Buy$270.00+14.81%Maintains
2 months ago
Outlook Therapeutics IncOTLK
3Buy$24.00+1,428.66%Maintains
2 months ago
Igc Pharma IncIGC
5Buy$4.25+1,284.36%Maintains
2 months ago
Genasys IncGNSS
2Buy$5.50+155.81%Maintains
5 months ago
Aim Immunotech IncAIMI
2Buy$4.50+4,636.84%Maintains
5 months ago
Datavault Ai IncDVLT
3Buy$11.00+1,100.87%Maintains
5 months ago
Gri Bio IncGRI
2Buy$13.00+566.67%Maintains
5 months ago
Intrusion IncINTZ
3Buy$11.00+780.00%Maintains
5 months ago
TravelzooTZOO
3Buy$23.00+62.66%Maintains
6 months ago
Pro Dex IncPDEX
2Buy$52.00-22.73%Maintains
6 months ago
Biolase IncBIOL
2Buy$2.00+1,450.39%Maintains
8 months ago
Mira Pharmaceuticals IncMIRA
1Buy$11.00+864.91%Initiates Coverage On
9 months ago
Jakks Pacific IncJAKK
1Buy$38.00N/AMaintains
a year ago
Booking Holdings IncBKNG
2Buy$3,900.00N/AMaintains
a year ago
Expedia Group IncEXPE
1Buy$168.00N/AMaintains
a year ago
Tripadvisor IncTRIP
1Buy$30.00N/AMaintains
a year ago
Algorhythm Holdings IncRIME
1Buy$4.00N/AInitiates Coverage On
a year ago
Heartsciences IncHSCS
1Buy$330.00N/AInitiates Coverage On
2 years ago
Vivos Therapeutics IncVVOS
1Buy$62.50N/AInitiates Coverage On
2 years ago
Autoweb IncAUTO
1Hold$0.39N/ADowngrades
3 years ago
Guardion Health Sciences IncGHSI
1Buy$37.50N/AInitiates Coverage On
3 years ago
Blackboxstocks IncBLBX
1Buy$24.00N/AInitiates Coverage On
3 years ago
Novabay Pharmaceuticals IncNBY
3Buy$4,900.00N/AMaintains
3 years ago
Activision Blizzard IncATVI
3Buy$95.00N/AMaintains
3 years ago
Gamestop CorpGME
8Sell$5.75N/AMaintains
3 years ago
Blue Nile IncNILE1
1Buy$6.00N/AInitiates Coverage On
3 years ago
Imac Holdings IncBACK
1BuyN/AN/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.